Fat-Derived Adult Stem Cells Targeted for Heart Disease Therapy
In yet another heart disease study, adult stem cells derived from adipose tissue are chosen as the most promising therapy.
September 27, 2009
In yet another heart disease study, adult stem cells derived from adipose tissue are chosen as the most promising therapy.
The U.S. company Stem Cell Therapy International has announced a merger with S. Korea’s Histostem.
In collaboration with a Hong Kong company, the U.S. biotech company BioTime announces the formation of a new subsidiary, to be headquartered in China.
Researchers at Johns Hopkins University are developing new therapies based upon methods of stimulating each person’s own naturally occurring endogenous adult stem cells.
A race horse who was scheduled for retirement is instead returning to his lucrative racing career after being successfully treated with autologous adult stem cell therapy.
The XCell-Center in Germany reports positive clinical results from 45 cerebral palsy patients who were treated with autologous adult stem cells derived from bone marrow, in whom 67% improved as a result of the treatment.